Skip to search formSkip to main contentSkip to account menu

Lamisil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
In a randomized, double‐blind, double‐placebo, multicentre study, terbinafine 250 mg daily for 12 weeks was compared with… 
Highly Cited
2000
Highly Cited
2000
A method using liquid chromatography/tandem mass spectrometry (LC/MS/MS) for the determination of terbinafine in human and… 
Highly Cited
1996
Highly Cited
1996
Several studies indicate that Pityrosporum ovale plays an important role in seborrhoeic dermatitis. Many of these are treatment… 
Review
1995
Review
1995
  • T. Jones
  • British Journal of Dermatology
  • 1995
  • Corpus ID: 2249014
This review summarizes the efficacy and tolerability of terbinafine (Lamisil®) in the treatment of dermatophytoses in children… 
Review
1994
Review
1994
  • A. Finlay
  • British Journal of Dermatology
  • 1994
  • Corpus ID: 12776297
Terbinafine (Lamisil®) is a new antifungal drug which is now available in many countries worldwide. This review seeks to… 
Highly Cited
1990
Highly Cited
1990
Lamid is a new antifungal drug which can be administered orrally and is effective against a broad range of dermatomycoses. This… 
1990
1990
The pharmacokinetics of terbinafine (Lamisil) have been studied in humans using both unlabelled and radiolabelled drug. Lamisil… 
Review
1989
Review
1989
  • J. C. Jensen
  • Clincal and Experimental Dermatology
  • 1989
  • Corpus ID: 31006428
Numerous studies have heen performed to describe the absorption, distribution, metabolism and excretion of terbinafine in healthy… 
Highly Cited
1989
Highly Cited
1989
Terbinafine (Lamisil) is the newest compound within a class of antimycotic drugs called allylamines. It is active against a broad… 
Highly Cited
1989
Highly Cited
1989
  • R. Savin
  • Clincal and Experimental Dermatology
  • 1989
  • Corpus ID: 25946890
Terbinafine (Lamisil) is the first safe and effective orally active agent in a new family of antifungal drugs, the allylamines…